Related Experiment Video
Updated: Jul 1, 2026

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
A Systematic Direct-to-Biology Approach Identified Potent Cereblon HaloPROTACs
Rebecca Stevens1,2, Kwok-Ho Chan1, Alice Moore1
1Research Technologies, Medicines Research Centre, GSK, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, U.K.
Abstract:
HaloTags have emerged as versatile tools for protein labeling, investigating target biology, and facilitating targeting protein degradation using synthetic ligands called HaloPROTACs. These chemical tools are heterobifunctional molecules consisting of a chloroalkane derivative linked to E3 ubiquitin ligase-recruiting moieties to artificially induce proximity between the ligase and target protein of interest fused to the HaloTag construct. Through this induced proximity, HaloPROTACs can facilitate temporal- and dose-dependent degradation of target proteins, enabling efficient cellular protein knockdown without the need for target-specific ligands. In this study, we developed cereblon (CRBN)-recruiting HaloPROTACs through the use of plate-based high-throughput synthesis and direct-to-biology screening. We evaluated over 100 structurally diverse CRBN HaloPROTACs in an FAK-tagged cell line, resulting in the identification of highly potent tools. Notably, HaloPROTACs incorporating dihydrouracil CRBN binders exhibited superior potency and selectivity compared with their IMiD-based counterparts. These newly developed CRBN-based HaloPROTACs represent a valuable addition to the existing HaloPROTAC toolkit, offering enhanced capabilities for advancing research on targeted protein degradation.
More Related Videos
07:22The Development and Application of Biophysical Assays for Evaluating Ternary Complex Formation Induced by Proteolysis Targeting Chimeras (PROTACS)
Published on: January 12, 2024
05:33High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
Published on: November 9, 2020